Researchers track antibiotic power against superbug infections

NCT ID NCT06717594

First seen Dec 29, 2025 · Last updated May 25, 2026 · Updated 20 times

Summary

This study observes 60 adults with hard-to-treat bacterial infections caused by carbapenem-resistant Enterobacterales (CRE). Participants receive either one or two antibiotics (ceftazidime/avibactam with or without fosfomycin). Researchers measure how well the drugs reach effective levels in the body and track infection markers over 7 days. The goal is to learn more about dosing and effectiveness, not to test a new cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAM NEGATIVE INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    RECRUITING

    Bologna, Bologna, 40138, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Instituto de Biomedicina de Sevilla (IBiS), Hospital Virgen Macarena/CSIC/Universidad de Sevilla

    RECRUITING

    Seville, Seville, 41013, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.